AGP Executive Report
Last update: 7 hours agoSurrogacy & maternal care: Texas AG Ken Paxton pushed for “life-saving care” for “Baby Gabriel” in a Dallas parentage/abortion dispute, renewing scrutiny of how state law can delay treatment for treatable conditions. Hospital billing pressure: Hospitals are increasingly moving toward upfront payment requirements as costs rise, shifting more financial risk to patients before care. Drug safety & fraud: Eli Lilly sued six companies over alleged illegal sales of experimental weight-loss drug retatrutide, targeting compounding pharmacies, med spas, and online sellers selling to consumers despite no FDA approval. Texas THC crackdown: Texas banned several hemp-derived THC products (including delta-8 and delta-10), while delta-9 THC remains legal—another shake-up for the state’s hemp market. Public health & access: Abortion laws in Texas are disrupting maternal care, with reported delays turning pregnancy complications into life-threatening crises. Infectious disease watch: Dallas County reported its first human case of West Nile virus. Healthcare workforce & tech: A new consortium of 12 hospital systems aims to speed and improve diagnostic AI workflows, especially in radiology.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.